MicroRNA (miR)-219a-5p has been implicated in the development of numerous progression of carcinoma and autoimmune diseases. However, whether miR-219a-5p is involved in the pathogenesis of inflammatory bowel disease (IBD) remains elusive. In this study, we demonstrated that miR-219a-5p expression was significantly decreased in the inflamed intestinal mucosa and peripheral blood (PB)-CD4+ T cells from patients with IBD. Proinflammatory cytokines (e.g., IL-6, IL-12, IL-23 and TNF-α) inhibited miR-219a-5p expression in CD4+ T cells in vitro. Lentivirus-mediated miR-219a-5p downregulation facilitated Th1/Th17 cell differentiation, whereas miR-219a-5p overexpression exerted an opposite effect. Luciferase assays confirmed that ETS variant 5 (ETV5) was a functional target of miR-219a-5p and ETV5 expression was significantly increased in the inflamed intestinal mucosa and PB-CD4+ T cells from IBD patients. ETV5 overexpression enhanced Th1/Th17 immune response through upregulating the phosphorylation of STAT3 and STAT4. Importantly, supplementation of miR-219a-5p ameliorated TNBS-induced intestinal mucosal inflammation, characterized by decreased IFN-γ+ CD4+ T cells and IL-17A+ CD4+ T cells infiltration in the colonic lamina propria. Our data thus reveal a novel mechanism whereby miR-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses. miR-219a-5p might be a target for the treatment of IBD.
Subscribe to Journal
Get full journal access for 1 year
only $92.33 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Shi, Y. et al. Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function. Mucosal Immunol. 11, 835–845 (2018).
Ma, C. et al. Critical role of CD6highCD4+ T cells in driving Th1/Th17 cell immune responses and mucosal inflammation in IBD. J. Crohn’s Colitis 13, 510–524 (2018).
De Souza, H. S. P. et al. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat. Rev. Gastroenterol. Hepatol. 14, 739–749 (2017).
Sartor, R. B. & Wu, G. D. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology 152, 327–339 (2017).
Schwerd, T. et al. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunol. 11, 562–574 (2018).
Geremia, A. & Arancibia-Carcamo, C. V. Innate lymphoid cells in intestinal inflammation. Front. Immunol. 8, 1296 (2017).
Citalan-Madrid, A. F. et al. Cortactin deficiency causes increased RhoA/ROCK1-dependent actomyosin contractility, intestinal epithelial barrier dysfunction, and disproportionately severe DSS-induced colitis. Mucosal Immunol. 10, 1237–1247 (2017).
Zhou, R. et al. JNK pathway-associated phosphatase/DUSP22 suppresses CD4(+) T-cell activation and Th1/Th17-cell differentiation and negatively correlates with clinical activity in inflammatory bowel disease. Front. Immunol. 8, 781 (2017).
Shi, T. et al. The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis. Mucosal Immunol. 10, 983–995 (2017).
Sanctuary, M. R. et al. miR-106a deficiency attenuates inflammation in murine IBD models. Mucosal Immunol. 12, 200–211 (2019).
Kaser, A. et al. Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573–621 (2010).
Morgan, M. E. et al. Toll-like receptor 6 stimulation promotes T-helper 1 and 17 responses in gastrointestinal-associated lymphoid tissue and modulates murine experimental colitis. Mucosal Immunol. 7, 1266–1277 (2014).
He, C. et al. MicroRNA 301A promotes intestinal inflammation and colitis-associated cancer development by inhibiting BTG1. Gastroenterology 152, 1434–1448 (2017).
Wu, W. et al. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD. Gut 64, 1755–1764 (2015).
Li, M. et al. Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3. Cell Death Dis. 8, e2699 (2017).
Koukos, G. et al. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology 145, 842–852 (2013).
Koukos, G. et al. A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium. Inflamm. Bowel Dis. 21, 996–1005 (2015).
Pei, X. F. et al. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease. Pathol. Res. Pract. 214, 1095–1104 (2018).
Li, J. et al. Critical role of alternative M2 skewing in miR-155 deletion-mediated protection of colitis. Front. Immunol. 9, 904 (2018).
Singh, U. P. et al. miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses. Immunology 143, 478–489 (2014).
Bruinsma, I. B. et al. Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS. J. Neuroinflamm. 14, 235 (2017).
Hu, X. M. et al. Downregulation of miR-219 enhances brain-derived neurotrophic factor production in mouse dorsal root ganglia to mediate morphine analgesic tolerance by upregulating CaMKIIgamma. Mol. Pain 12, pii: 1744806916666283 (2016).
Rius, B. et al. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. FASEB J. 28, 836–848 (2014).
Recchiuti, A. et al. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J. 25, 544–560 (2011).
Huang, N. et al. MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett. 586, 884–891 (2012).
Huang, L. X. et al. microRNA-219-5p inhibits epithelial−mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1. Cancer Sci. 108, 1985–1995 (2017).
Wei, C. et al. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/beta-catenin signaling pathway. Gene 637, 25–32 (2017).
He, C. et al. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-alpha in IBD. Gut 65, 1938–1950 (2016).
Ichiyama, K. et al. The microRNA-183-96-182 cluster promotes T helper 17 cell pathogenicity by negatively regulating transcription factor Foxo1 expression. Immunity 44, 1284–1298 (2016).
Deng, L. et al. Involvement of microRNA-23b in TNF-alpha-reduced BMSC osteogenic differentiation via targeting runx2. J. Bone Miner. Metab. 36, 648–660 (2018).
Xie, M. et al. NF-kappaB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3. J. Autoimmun. 102, 96–113 (2019).
Lin, H. Y. et al. STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells. Br. J. Cancer 109, 731–738 (2013).
Cheng, X. et al. ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB. Int. J. Cancer 145, 179–191 (2019).
Pham, D. et al. The transcription factor Etv5 controls TH17 cell development and allergic airway inflammation. J. Allergy Clin. Immunol. 134, 204–214 (2014).
Yu, S. et al. IL-12 induced the generation of IL-21- and IFN-gamma-co-expressing poly-functional CD4+ T cells from human naive CD4+ T cells. Cell Cycle 14, 3362–3372 (2015).
Kubo, S. et al. Janus kinase inhibitor baricitinib modulates human innate and adaptive immune system. Front. Immunol. 9, 1510 (2018).
Delgoffe, G. M. et al. Interpreting mixed signals: the cell’s cytokine conundrum. Curr. Opin. Immunol. 23, 632–638 (2011).
Nagashima, H. et al. Regulation of interleukin-6 receptor signaling by TNF receptor-associated factor 2 and 5 during differentiation of inflammatory CD4(+) T cells. Front. Immunol. 9, 1986 (2018).
Wirtz, S. et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat. Protoc. 12, 1295–1309 (2017).
Zhou, G. et al. Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting TH1/TH17 cell differentiation in patients with inflammatory bowel diseases. J. Allergy Clin. Immunol. 142, 1218–1228 (2018).
Yang, W. et al. Critical role of ROCK2 activity in facilitating mucosal CD4(+) T cell activation in inflammatory bowel disease. J. Autoimmun. 89, 125–138 (2018).
Huang, Z. et al. miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12beta during murine colitis and human Crohn’s disease. Gut 63, 1247–1257 (2014).
Cheng, X. et al. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn’s disease. Sci. Rep. 5, 10397 (2015).
Yu, M. et al. MicroRNA-590-5p Inhibits Intestinal Inflammation by Targeting YAP. J. Crohn’s. Colitis 12, 993–1004 (2018).
Fitzpatrick, L. R. Novel pharmacological approaches for inflammatory bowel disease: targeting key intracellular pathways and the IL-23/IL-17 axis. Int. J. Inflamm. 2012, 389404 (2012).
Radi, Z. A. et al. Pharmacologic evaluation of sulfasalazine, FTY720, and anti-IL-12/23p40 in a TNBS-induced Crohn’s disease model. Dig. Dis. Sci. 56, 2283–2291 (2011).
Van Der Heijden, T. et al. The IL-12 cytokine family in cardiovascular diseases. Cytokine 122, 154188 (2017).
Wei, B. & Pei, G. microRNAs: critical regulators in Th17 cells and players in diseases. Cell. Mol. Immunol. 7, 175–181 (2010).
Liu, Y. et al. MiR-155 inhibition ameliorates 2, 4, 6-Trinitrobenzenesulfonic acid (TNBS)-induced experimental colitis in rat via influencing the differentiation of Th17 cells by Jarid2. Int. Immunopharmacol. 64, 401–410 (2018).
Wang, H. et al. miR-219 cooperates with miR-338 in myelination and promotes myelin repair in the CNS. Dev. Cell 40, 566–582 (2017).
Thieu, V. T. et al. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 29, 679–690 (2008).
Ouyang, W. et al. The Ets transcription factor ERM is Th1-specific and induced by IL-12 through a Stat4-dependent pathway. Proc. Natl. Acad. Sci. USA 96, 3888–3893 (1999).
Wirtz, S. et al. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141, 1875–1886 (2011).
This work was supported by grants from the National Natural Science Foundation of China (81700494), Jiangsu Provincial Key Research and Development Program (BE2017692) and supporting funds from Zhenjiang Municipal Health Commission and Affiliated People’s Hospital of Jiangsu University (K201733, K201741).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shi, Y., Dai, S., Qiu, C. et al. MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease. Mucosal Immunol 13, 303–312 (2020). https://doi.org/10.1038/s41385-019-0216-7
Sevoflurane attenuates cardiomyocyte apoptosis by mediating the miR-219a/AIM2/TLR4/MyD88 axis in myocardial ischemia/reperfusion injury in mice
Cell Cycle (2020)
Cancer Cell International (2020)